Article Text

Download PDFPDF
Comparison of e-cigarette marketing and availability in tobacco retail outlets among diverse low-income communities in California
  1. Patricia Escobedo1,
  2. Robert Garcia2,
  3. Claradina Soto1,
  4. Yaneth Rodriguez1,
  5. Rosa Barahona1,
  6. Lourdes Baezconde-Garbanati1
  1. 1Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA
  2. 2Health Science Center School of Public Health, Texas A&M University College Station, College Station, Texas, USA
  1. Correspondence to Patricia Escobedo, Preventive Medicine, University of Southern California, Los Angeles, CA 90007, USA; pescobed{at}usc.edu

Footnotes

  • Contributors PE and LB-G conceptualised the study. PE led data analysis and wrote the article. RG, CS and RB contributed to writing and revisions. YR managed the data collection and contributed to revisions. LB-G contributed to revisions and was the principal investigator of the broader study.

  • Funding This paper was supported by the National Cancer Institute of the National Institutes of Health (NCI-NIH), the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) for the USC Tobacco Center for Regulatory Sciences in Vulnerable Populations (NCIP50CA180905) (Pentz/Samet, PIs)—Project 2—Maximizing Tobacco Retailers Participation in FDA Regulation in Vulnerable Ethnic Communities (Baezconde-Garbanati, Project Leader). We also wish to acknowledge the NCI (Grant number: P30CA014089) and the Norris Comprehensive Cancer Center.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI-NIH, FDA or USC.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The university’s Institutional Review Board approved all procedures.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors PE and LB-G conceptualised the study. PE led data analysis and wrote the article. RG, CS and RB contributed to writing and revisions. YR managed the data collection and contributed to revisions. LB-G contributed to revisions and was the principal investigator of the broader study.

  • Funding This paper was supported by the National Cancer Institute of the National Institutes of Health (NCI-NIH), the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) for the USC Tobacco Center for Regulatory Sciences in Vulnerable Populations (NCIP50CA180905) (Pentz/Samet, PIs)—Project 2—Maximizing Tobacco Retailers Participation in FDA Regulation in Vulnerable Ethnic Communities (Baezconde-Garbanati, Project Leader). We also wish to acknowledge the NCI (Grant number: P30CA014089) and the Norris Comprehensive Cancer Center.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI-NIH, FDA or USC.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The university’s Institutional Review Board approved all procedures.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.